ADDRESS-2 research project is sponsored by Imperial College London and currently funded by Diabetes UK. It has five main objectives:
- Maximize the opportunities for people newly diagnosed with type 1 diabetes to enter into early intervention trials by making them aware of these trials
- Provide opportunities to take part in observational studies soon after a diagnosis of type 1 diabetes, particularly for anyone who doesn’t wish to take part in an intervention trial
- Share opportunities and signpost to studies recruiting people with type 1 diabetes for anyone who doesn’t feel able to take part in research at the time of diagnosis, but may want to after adapting to living with the condition
- Facilitate people who may have a high risk of developing type 1 diabetes joining new prevention trials before the condition develops, particularly through siblings of ADDRESS-2 participants